Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma

Stereotactic body radiotherapy (SBRT) is a novel noninvasive treatment for unresectable hepatocellular carcinoma (HCC). Whether its efficacy is comparable to radiofrequency ablation (RFA), a recommended therapy for unresectable HCC, is unknown. The present study aims to compare the clinical outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Ren, Ng, Kelvin K., Chen, Wenqi, Yang, Weihong, Zhu, Hongtao, Cheung, Tan-To, Chiang, Chi-Leung, Wong, Tiffany C.L., Kong, Feng-Ming, Wu, G., Lo, Chung-Mau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797553/
https://www.ncbi.nlm.nih.gov/pubmed/35089192
http://dx.doi.org/10.1097/MD.0000000000028545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797553/
https://www.ncbi.nlm.nih.gov/pubmed/35089192
http://dx.doi.org/10.1097/MD.0000000000028545

Ejemplares similares